The award-winning Insurance United Against Dementia (IUAD) campaign has announced the appointment of Chris Lay, (below) CEO of Marsh McLennan UK, as its new Campaign Chair, as it enters an ambitious second phase following the achievement of its initial £10 million fundraising target. Here are the details;
This new chapter comes at a critical moment for dementia research, following the approval by the MHRA in late 2024 of two drugs shown to slow the progression of Alzheimer’s disease. It marks a turning point in the fight against dementia, but lasting impact will depend on sustained momentum, investment and industry collaboration.
Under Chris’s leadership, IUAD aims to propel the campaign into its next chapter – continuing to unite the industry behind the cause to accelerate progress towards a world where dementia no longer devastates lives. Chris brings with him a wealth of experience having held a variety of senior leadership positions in the UK and globally during his career. Chris currently serves on The Leadership Council of The CityUK, and The President’s Committee of The Confederation of British Business (CBI), as well as being a former President of The Insurance Institute of London. As Chair of IUAD, Chris is excited to work with the team through strategic fundraising and awareness-raising initiatives to help end the devastation caused by dementia.
Chris Lay, incoming Chair of the IUAD Board said:
“When I was asked to take on this role, I felt a deep sense of pride, having seen firsthand what the campaign has already achieved across the industry. I want to congratulate and thank Richard Dudley, Chris Wallace, the IUAD board members, and all the supporters to date for their terrific achievements.
“We’re at a truly pivotal moment, not just for IUAD, but for the wider dementia landscape. In the past year, we’ve seen groundbreaking developments, including the approval of two drugs that can successfully slow the progression of Alzheimer’s disease. These breakthroughs bring real hope.
“Now is the time for our industry to double down, building on this momentum and continuing to drive meaningful change for the nearly one million people living with dementia in the UK. I’m excited and honoured to be part of the IUAD mission.”
The IUAD campaign has, to date, worked with over 140 organisations across the industry with phase two of the campaign seeking to maintain these relationships and inspire and galvanise many more to get involved. It is with thanks to the leadership of the Board, and the support of those in the industry, that IUAD has helped Alzheimer’s Society to achieve amazing things, including, amongst many others, supporting 158 researchers to develop innovative methods of diagnosis and better solutions for dementia care and the creation of the organisations’ Companion Calls service, offering critical comfort and friendship through 140,000 calls to more than 5,000 people affected by dementia.
To find out more about the success of the campaign to date, as well as what is next, visit alzheimers.org.uk/iuad or follow the dedicated LinkedIn page @Insurance United Against Dementia.
Be the first to comment